Two Treatment Modalities for Myogenous Temporomandibular Disorders
Recruiting
N/A
Interventional Study
TMD
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 45
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 32 (estimated)
- Sponsor
- Alexandria University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Temporomandibular disorder (TMD) is a common condition with multifactorial etiology, including trauma, emotional stress, parafunctional habits, and occlusal discrepancies. TMD may be classified as myogenous, involving the masticatory and cervical muscles, or arthrogenous, affecting the temporomandibular joint structures. Management approaches range from noninvasive to invasive methods. The intraor…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participants presenting with pain score grading at least 4 out of 10 on NRS.
* Participants with fully dentate type I occlusion.
* Patients experiencing no neurological disorders.
Exclusion Criteria:
* Patients with arthrogenous TMJ will be excluded by Magnetic Resonance Ima…
Contacts